The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Open accessAbstract
Surface functionalization of liposomes can play a key role in overcoming the current limitations of nanocarriers to treat solid tumors, i.e., biological barriers and physiological factors. The phospholipid vesicles (liposomes) containing anticancer agents produce fewer side effects than non-liposomal anticancer formulations, and can effectively target the solid tumors. This article reviews information about the strategies for targeting of liposomes to solid tumors along with the possible targets in cancer cells, i.e., extracellular and intracellular targets and targets in tumor microenvironment or vasculature. Targeting ligands for functionalization of liposomes with relevant surface engineering techniques have been described. Stimuli strategies for enhanced delivery of anticancer agents at requisite location using stimuli-responsive functionalized liposomes have been discussed. Recent approaches for enhanced delivery of anticancer agents at tumor site with relevant surface functionalization techniques have been reviewed. Finally, current challenges of functionalized liposomes and future perspective of smart functionalized liposomes have been discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Patra, S., Roy, E., Madhuri, R., & Sharma, P. K. (2015) · Biomaterials Science · doi:10.1039/c5bm00433k · Cited by 49
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Hydrogels in drug delivery: Progress and challenges
Hoare, T. R., & Kohane, D. S. (2008) · Polymer · doi:10.1016/j.polymer.2008.01.027 · Cited by 3,776
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
Albanese, A., Tang, P. S., & Chan, W. C. W. (2012) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071811-150124 · Cited by 3,633
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
Maeda, H., Nakamura, H., & Fang, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.002 · Cited by 2,376
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912
Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,809
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains
Goodman, C. M., McCusker, C. D., Yilmaz, T., & Rotello, V. M. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049951i · Cited by 1,601
Iqbal, N., & Iqbal, N. (2014) · Molecular Biology International · doi:10.1155/2014/852748 · Cited by 1,381
Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities
Cheng, Z., Al Zaki, A., Hui, J. Z., Muzykantov, V. R., & Tsourkas, A. (2012) · Science · doi:10.1126/science.1226338 · Cited by 1,322
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Effects of nanomaterial physicochemical properties on in vivo toxicity
Aillon, K. L., Xie, Y., El-Gendy, N., Berkland, C. J., & Forrest, M. L. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.010 · Cited by 811
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Nanoparticles in drug delivery: Past, present and future
Couvreur, P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.010 · Cited by 696
Cell-penetrating peptides: breaking through to the other side
Koren, E., & Torchilin, V. P. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.012 · Cited by 670
Liposome application: problems and prospects.
Barenholz, Y. (2001) · Current Opinion in Colloid & Interface Science · doi:10.1016/s1359-0294(00)00090-x · Cited by 659
Current Trends in The Use of Liposomes for Tumor Targeting
Deshpande, P. P., Biswas, S., & Torchilin, V. P. (2013) · Nanomedicine · doi:10.2217/nnm.13.118 · Cited by 657
Zylberberg, C., & Matosevic, S. (2016) · Drug Delivery · doi:10.1080/10717544.2016.1177136 · Cited by 627
Passive and Active Drug Targeting: Drug Delivery to Tumors as an Example
Torchilin, V. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_1 · Cited by 573
RECENT APPROACHES TO INTRACELLULAR DELIVERY OF DRUGS AND DNA AND ORGANELLE TARGETING
Torchilin, V. P. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095735 · Cited by 543
Gold nanoparticles: opportunities and challenges in nanomedicine
Arvizo, R., Bhattacharya, R., & Mukherjee, P. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425241003777010 · Cited by 538
Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma
Gupta, S., Srivastava, M., Ahmad, N., Bostwick, D. G., & Mukhtar, H. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000101)42:1<73::aid-pros9>3.0.co;2-g · Cited by 526
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Hatakeyama, H., Akita, H., & Harashima, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00059 · Cited by 495
On the formulation of pH-sensitive liposomes with long circulation times
Simões, S. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.038 · Cited by 483
pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates
Felber, A. E., Dufresne, M.-H., & Leroux, J.-C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.09.006 · Cited by 478
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy
Pradhan, P., Giri, J., Rieken, F., Koch, C., Mykhaylyk, O., Döblinger, M., Banerjee, R., Bahadur, D., & Plank, C. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.002 · Cited by 468
Phospholipid spherules (liposomes) as a model for biological membranes
Sessa, G., & Weissmann, G. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43097-4 · Cited by 446
Liposomes for use in gene delivery
Balazs, D. A., & Godbey, W. (2011) · Journal of Drug Delivery · doi:10.1155/2011/326497 · Cited by 441
Mamot, C., Drummond, D. C., Noble, C. O., Kallab, V., Guo, Z., Hong, K., Kirpotin, D. B., & Park, J. W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1093 · Cited by 382
Liposomal Delivery Systems: Design Optimization and Current Applications
Abu Lila, A. S., & Ishida, T. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b16-00624 · Cited by 382
Challenges in Development of Targeted Liposomal Therapeutics
Sawant, R. R., & Torchilin, V. P. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9330-0 · Cited by 379
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1007504613351 · Cited by 349 · cited 1×
“Polyvalent-cationic liposomes have shown pulmonary toxicity in murine model because of reactive-oxygen intermediates [158].”
BackgroundBarriers to drug delivery in solid tumors
Sriraman, S. K., Aryasomayajula, B., & Torchilin, V. P. (2014) · Tissue Barriers · doi:10.4161/tisb.29528 · Cited by 338
Improvement of drug safety by the use of lipid-based nanocarriers
Lim, S. B., Banerjee, A., & Önyüksel, H. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.002 · Cited by 324
Yu, M., Jambhrunkar, S., Thorn, P., Chen, J., Gu, W., & Yu, C. (2013) · Nanoscale · doi:10.1039/c2nr32145a · Cited by 316
Roles of Fibroblast Growth Factor Receptors in Carcinogenesis
Haugsten, E. M., Wiedlocha, A., Olsnes, S., & Wesche, J. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0168 · Cited by 315
Metalloproteinases and their inhibitors in tumor angiogenesis
Handsley, M. M., & Edwards, D. R. (2005) · International Journal of Cancer · doi:10.1002/ijc.20945 · Cited by 307
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro
Saul, J. M., Annapragada, A., Natarajan, J. V., & Bellamkonda, R. V. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00295-5 · Cited by 303
(2000) · PubMed · Cited by 295
Jiang, L., Li, L., He, X., Yi, Q., He, B., Cao, J., Pan, W., & Gu, Z. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.004 · Cited by 294
Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides
Dissanayake, S., Denny, W. A., Gamage, S., & Sarojini, V. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.02.006 · Cited by 280
Biswas, S., Dodwadkar, N. S., Deshpande, P. P., & Torchilin, V. P. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.009 · Cited by 279
Targeted delivery of doxorubicin using stealth liposomes modified with transferrin
Li, X., Ding, L., Xu, Y., Wang, Y., & Ping, Q. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.01.023 · Cited by 274
Maruyama, K., Takizawa, T., Yuda, T., Kennel, S. J., Huang, L., & Iwatsuru, M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)00263-o · Cited by 265
Stimulus-responsive nanopreparations for tumor targeting
Zhu, L., & Torchilin, V. P. (2013) · Integrative Biology · doi:10.1039/c2ib20135f · Cited by 258
Fenske, D. B., & Cullis, P. R. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.25 · Cited by 253
Zhao, Y., Ren, W., Zhong, T., Zhang, S., Huang, D., Guo, Y., Yao, X., Wang, C., Zhang, W.-Q., Zhang, X., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.006 · Cited by 252
Self-citationManjappa, A. S., Chaudhari, K. R., Venkataraju, M. P., Dantuluri, P., Nanda, B., Sidda, C., Sawant, K. K., & Ramachandra Murthy, R. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.002 · Cited by 236
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
Chi, Y., Yin, X., Sun, K., Feng, S., Liu, J., Chen, D., Guo, C., & Wu, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.027 · Cited by 219
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
Alshaer, W., Hillaireau, H., Vergnaud, J., Ismail, S., & Fattal, E. (2015) · Bioconjugate Chemistry · doi:10.1021/bc5004313 · Cited by 200
Functionalized‐Quantum‐Dot–Liposome Hybrids as Multimodal Nanoparticles for Cancer
Al‐Jamal, W. T., Al‐Jamal, K. T., Bomans, P. H., Frederik, P. M., & Kostarelos, K. (2008) · Small · doi:10.1002/smll.200701043 · Cited by 199
Nanotechnology-based drug delivery systems for treatment of oral cancer: a review
Calixto, G., Fonseca-Santos, B., Chorilli, M., & Bernegossi, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61670 · Cited by 194
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Bertagnolli, M. M., Eagle, C. J., Zauber, A. G., Redston, M., Breazna, A., Kim, K., Tang, J., Rosenstein, R. B., Umar, A., Bagheri, D., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0206 · Cited by 193
A critical review of lipid-based nanoparticles for taxane delivery
Feng, L., & Mumper, R. J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2012.07.006 · Cited by 191
Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
Durymanov, M. O., Rosenkranz, A. A., & Sobolev, A. S. (2015) · Theranostics · doi:10.7150/thno.11742 · Cited by 189
Pillai, G. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/2/00109 · Cited by 187
EGFR Signaling in Colorectal Carcinoma
Krasinskas, A. M. (2011) · Pathology Research International · doi:10.4061/2011/932932 · Cited by 184
Liposomal Drug Delivery: A Versatile Platform for Challenging Clinical Applications
Madni, A., Sarfraz, M., Rehman, M., Ahmad, M., Akhtar, N., Ahmad, S., Tahir, N., Ijaz, S., Al-Kassas, R., & Löbenberg, R. (2014) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3cp55 · Cited by 176
Drug Targeting Strategies in Cancer Treatment: An Overview
L. Arias, J. (2011) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955711793564024 · Cited by 176
Piktel, E., Niemirowicz, K., Wątek, M., Wollny, T., Deptuła, P., & Bucki, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0193-x · Cited by 171
A liposome-based nanostructure for aptamer directed delivery
Kang, H., O’Donoghue, M. B., Liu, H., & Tan, W. (2010) · Chem. Commun. · doi:10.1039/b916911c · Cited by 169
Liposomal Antioxidants for Protection against Oxidant-Induced Damage
Suntres, Z. E. (2011) · Journal of Toxicology · doi:10.1155/2011/152474 · Cited by 169
Li, S., Goins, B., Zhang, L., & Bao, A. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300175d · Cited by 168
Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes
Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., Yasuda, J., Obata, K., Kikuchi, H., Ishida, T., et al. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.037 · Cited by 165
Zong, T., Mei, L., Gao, H., Cai, W., Zhu, P., Shi, K., Chen, J., Wang, Y., Gao, F., & He, Q. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500057n · Cited by 160
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Gosk, S., Moos, T., Gottstein, C., & Bendas, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.12.021 · Cited by 158
Millard, M., Yakavets, I., Zorin, V. P., Kulmukhamedova, A., Marchal, S., & Bezdetnaya, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s146927 · Cited by 149
Baek, S. E., Lee, K. H., Park, Y. S., Oh, D., Oh, S., Kim, K., & Kim, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.018 · Cited by 148
Needham, D., Park, J.-Y., Wright, A. M., & Tong, J. (2012) · Faraday Discussions · doi:10.1039/c2fd20111a · Cited by 148
Bioavailability of Polyphenol Liposomes: A Challenge Ahead
Mignet, N., Séguin, J., & Chabot, G. G. (2013) · Pharmaceutics · doi:10.3390/pharmaceutics5030457 · Cited by 147
Targeting Carbonic Anhydrase IX Activity and Expression
Mahon, B. P., Pinard, M. A., & McKENNA, R. V. (2015) · Molecules · doi:10.3390/molecules20022323 · Cited by 142
Sou, K., Endo, T., Takeoka, S., & Tsuchida, E. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990135y · Cited by 140
Pillai, G. (2014) · SOJ Pharmacy & Pharmaceutical Sciences · doi:10.15226/2374-6866/1/1/00109 · Cited by 135
Aptamer-Mediated Targeted Delivery of Therapeutics: An Update
Catuogno, S., Esposito, C. L., & de Franciscis, V. (2016) · Pharmaceuticals · doi:10.3390/ph9040069 · Cited by 134
From “Banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010
Deamer, D. W. (2010) · The FASEB Journal · doi:10.1096/fj.10-0503 · Cited by 129
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
Munyendo, W. L. L., Lv, H., Benza-Ingoula, H., Baraza, L. D., & Zhou, J. (2012) · Biomolecules · doi:10.3390/biom2020187 · Cited by 128
Iron Deprivation in Cancer––Potential Therapeutic Implications
Heath, J. L., Weiss, J. M., Lavau, C., & Wechsler, D. S. (2013) · Nutrients · doi:10.3390/nu5082836 · Cited by 126
Zhang, Y., Zhai, M., Chen, Z., Han, X., Yu, F., Li, Z., Xie, X., Han, C., Lian, Y., Yang, Y., et al. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1344334 · Cited by 125
Yoshizaki, Y., Yuba, E., Sakaguchi, N., Koiwai, K., Harada, A., & Kono, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.077 · Cited by 123
Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid
Sriraman, S. K., Salzano, G., Sarısözen, C., & Torchilin, V. P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.05.023 · Cited by 123
RGD-TPGS decorated theranostic liposomes for brain targeted delivery
Sonali, Singh, R. P., Sharma, G., Kumari, L., Koch, B., Singh, S. K., Bharti, S., Rajinikanth, P. S., Pandey, B. L., & Muthu, M. S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.07.058 · Cited by 119
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
Eloy, J. O., Petrilli, R., Chesca, D. L., Saggioro, F. P., Lee, R. J., & Marchetti, J. M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.02.020 · Cited by 119
Digestion and depletion of abundant proteins improves proteomic coverage
Fonslow, B. R., Stein, B. D., Webb, K. J., Xu, T., Choi, J. H., Park, S. K., & Yates, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2250 · Cited by 107
Clares, B., Ortiz, R. A. B., Sáez-Fernández, E., Prados, J. C., Melguizo, C., Cabeza, L., Ortíz, R., & Arias, J. L. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.01.028 · Cited by 101
WICKI, A. N., Rochlitz, C. F., Orleth, A., Ritschard, R., Albrecht, I., Herrmann, R., Christofori, G., & Mamot, C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1102 · Cited by 101
Lin, C., Wong, B. C. K., Chen, H., Bian, Z., Zhang, G., Zhang, X., Riaz, M. K., Tyagi, D., Lin, G., Zhang, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00957-4 · Cited by 101
Self-citationAptamer-functionalized hybrid nanoparticle for the treatment of breast cancer
Powell, D., Chandra, S., Dodson, K., Shaheen, F., Wiltz, K., Ireland, S. K., Syed, M., Dash, S., Wiese, T. E., Mandal, T. K., et al. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.01.011 · Cited by 100
Chen, Z., Deng, Zhao, Z., & Tao, T. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33541 · Cited by 99
CPP-Assisted Intracellular Drug Delivery, What Is Next?
Ye, J., Liu, E., Yu, Z., Pei, X., Chen, S., Zhang, P., Shin, M. C., Gong, J., He, H., & Yang, V. C.-M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111892 · Cited by 97
Paolinelli, R., Corada, M., Orsenigo, F., & Dejana, E. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.11.012 · Cited by 93
Liposomal Drug Delivery Systems for Targeted Cancer Therapy: Is Active Targeting the Best Choice?
Fathi, S., & Oyelere, A. K. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0135 · Cited by 93
Koshkaryev, A., Piroyan, A., & Torchilin, V. P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.1.18871 · Cited by 92
Stimuli-responsive liposomes for the delivery of nucleic acid therapeutics
Movahedi, F., Hu, R. G., Becker, D. L., & Xu, C. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.03.006 · Cited by 90
Al-Ahmady, Z. S., Chaloin, O., & Kostarelos, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.013 · Cited by 86
Biswas, S., Dodwadkar, N. S., Sawant, R. R., Koshkaryev, A., & Torchilin, V. P. (2011) · Journal of drug targeting · doi:10.3109/1061186x.2010.536983 · Cited by 86
Li, H., Yang, X., Zhou, Z., Wang, K., Li, C., Qiao, H., Oupický, D., & Sun, M. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.06.029 · Cited by 83
Ta, T., Bartolak‐Suki, E., Park, E.-J., Karrobi, K., McDannold, N. J., & Porter, T. M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.013 · Cited by 77
Moosavian, S. A., Abnous, K., Badiee, A., & Jaafari, M. R. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.009 · Cited by 76
Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA
Mikhaylova, M., Stasinopoulos, I. A., Katō, Y., Artemov, D., & Bhujwalla, Z. M. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.79 · Cited by 73
Patel, J. D., O’Carra, R., Jones, J., Woodward, J. G., & Mumper, R. J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9154-7 · Cited by 72
Xie, Y., Ding, Y., Sun, D., Wang, G., Hongge, Y., Xu, H., Wang, Z., & Chen, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92519 · Cited by 71
Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging
Portnoy, E., Lecht, S., Lazarovici, P., Danino, D., & Magdassi, S. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.01.001 · Cited by 64
Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells
Limasale, Y. D. P., Tezcaner, A., Özen, C., Keskin, D. S., & Banerjee, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.016 · Cited by 64
Li, Q., Tang, Q., Zhang, P., Wang, Z., Zhao, T., Zhou, J., Li, H., Ding, Q., Li, W., Hu, F., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.009 · Cited by 60
Zhang, X., Lin, C., Lü, A., Lin, G., Chen, H., Liu, Q., Yang, Z., & Zhang, H. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1340361 · Cited by 58
Self-citationLinton, S. S., Sherwood, S. G., Drews, K. C., & KESTER, M. A. (2015) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1358 · Cited by 56
Integrin-targeted paclitaxel nanoliposomes for tumor therapy
Meng, S., Su, B., Li, W., Ding, Y., Tang, L., Zhou, W., Song, Y., & Caicun, Z. (2010) · Medical Oncology · doi:10.1007/s12032-010-9621-1 · Cited by 53
Aptamer-Modified Temperature-Sensitive Liposomal Contrast Agent for Magnetic Resonance Imaging
Zhang, K., Liu, M., Tong, X., Sun, N., Zhou, L., Cao, Y., Wang, J., Zhang, H., & Pei, R. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00250 · Cited by 52
Cyclooxygenase-1 and -2 are expressed by human T cells
Pablos, J. L., Santiago, B., Carreira, P. E., Galindo-Izquierdo, M., & Gómez-Reino, J. J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00780.x · Cited by 51
Alavizadeh, S. H., Akhtari, J., Badiee, A., Golmohammadzadeh, S., & Jaafari, M. R. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1121987 · Cited by 51
Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy
Lin, C., Ng, H., Pan, W., Chen, H., Zhang, G., Bian, Z., Lü, A., & Yang, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125995 · Cited by 49
Self-citationYoshizaki, Y., Yuba, E., Komatsu, T., Udaka, K., Harada, A., & Kono, K. (2016) · Molecules · doi:10.3390/molecules21101284 · Cited by 48
Yang, Z., Wong, B. C. K., Zhang, H., Qin, L., Chen, H., Lü, A., & Chen, F. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s63235 · Cited by 47
Self-citationBenhabbour, S. R., Luft, J. C., Kim, D., Jain, A., Wadhwa, S., Parrott, M. C., Liu, R., DeSimone, J. M., & Mumper, R. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.013 · Cited by 46
Han, H. D., Jeon, Y. W., Kwon, H. J., Jeon, H. N., Byeon, Y., Lee, C. O., Cho, S. H., & Shin, B. C. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.06.019 · Cited by 44
Stuart, C. H., Singh, R. N., Smith, T. L., D’Agostino, R., Caudell, D. L., Balaji, K., & Gmeiner, W. H. (2016) · Nanomedicine · doi:10.2217/nnm-2015-0017 · Cited by 43
Li, T., Amari, T., Semba, K., Yamamoto, T. S., & Takeoka, S. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.11.018 · Cited by 41
Rusnati, M., Dell’Era, P., Urbinati, C., Tanghetti, E., Massardi, M. L., Nagamine, Y., Monti, E., & Presta, M. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.3.369 · Cited by 40
Anti-EphA10 antibody-conjugated pH-sensitive liposomes for specific intracellular delivery of siRNA
Zang, X., Ding, H., Zhao, X., Li, X., Du, Z., Hu, H., Qiao, M., Chen, D., Deng, Y., & Zhao, X. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s107952 · Cited by 40
Peptide-Based Cancer-Targeted DDS and Molecular Imaging
Hagimori, M., Fuchigami, Y., & Kawakami, S. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00098 · Cited by 35
Lee, Y. K., Lee, T. S., Song, I. H., Jeong, H. Y., Kang, S. J., Kim, M. W., Ryu, S. H., Jung, I. H., Kim, J. S., & Park, Y. S. (2015) · Cancer Gene Therapy · doi:10.1038/cgt.2015.18 · Cited by 32
Zuo, T., Guan, Y., Chang, M., Zhang, F., Lu, S., Wei, T., Shao, W., & Lin, G. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.07.056 · Cited by 32
Yang, Y., Yang, Y., Xie, X., Xu, X., Xia, X., Wang, H., Li, L., Dong, W., Ma, P., & Liu, Y. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.035 · Cited by 31
Ultrasound-Responsive Liposomes
Huang, S. L. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-360-2_7 · Cited by 29
Pricing in the Market for Anticancer Drugs
Howard, D. H., Bach, P., Berndt, E. R., & Conti, R. M. (2015) · National Bureau of Economic Research · doi:10.3386/w20867 · Cited by 28
Review article : stability and uses of liposomes.
Riaz, M. (1995) · PubMed · Cited by 25
Self-citationStrategies to improve the EPR effect for the delivery of anti-cancer nanomedicines
Danhier, F., & Véronique Préat, A. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.808 · Cited by 21
Ng, H., Lü, A., Lin, G., Qin, L., & Yang, Z. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010230 · Cited by 17
Self-citationPhospholipid Liposomes: Properties and Potential Use in Flavor Encapsulation
Weiner, N. (1997) · ACS symposium series · doi:10.1021/bk-1995-0610.ch016 · Cited by 14
Anticancer Drug — Friend or Foe
Taşkın‐Tok, T., & Gowder, S. J. (2014) · InTech eBooks · doi:10.5772/58552 · Cited by 11
Surface Engineering: Incorporation of Bioactive Compound
Riaz, M. K., Tyagi, D., & Yang, Z. (2017) · Nanomedicine and nanotoxicology · doi:10.1007/978-981-10-5864-6_6 · Cited by 8
Self-citationBrekel, A. J. (1996) · Lung Cancer · doi:10.1016/s0169-5002(97)89511-6 · Cited by 3
Cited by
Design of liposomes as drug delivery system for therapeutic applications
Guimarães, D., Cavaco-Paulo, A., & Nogueira, E. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120571 · Cited by 1,196
Lombardo, D., Kiselev, M. A., & Caccamo, M. T. (2019) · Journal of Nanomaterials · doi:10.1155/2019/3702518 · Cited by 864
Liposomal Drug Delivery Systems and Anticancer Drugs
Olusanya, T., Haj Ahmad, R., Ibegbu, D., Smith, J., & Elkordy, A. (2018) · Molecules · doi:10.3390/molecules23040907 · Cited by 603
Nanomedicine review: clinical developments in liposomal applications
Beltrán-Gracia, E., López-Camacho, A., Higuera-Ciapara, I., Velázquez-Fernández, J. B., & Vallejo-Cardona, A. A. (2019) · Cancer Nanotechnology · doi:10.1186/s12645-019-0055-y · Cited by 513
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Metadata
- Authors
- Riaz, M., Riaz, M., Zhang, X., Lin, C., Wong, K., Chen, X., Zhang, G., Lu, A., & Yang, Z.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-01-09
- Volume
- 19
- Issue
- 1
- Pages
- 195
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2783580099
- Cited by
- 509
- References
- 143
- FWCI
- 15.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.